Viewing Study NCT01459250


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-02-21 @ 6:44 PM
Study NCT ID: NCT01459250
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2011-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module